Matches in Wikidata for { <http://www.wikidata.org/entity/Q79110018> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q79110018 description "clinical trial" @default.
- Q79110018 description "ensayu clínicu" @default.
- Q79110018 description "klinisch onderzoek" @default.
- Q79110018 description "клінічне випробування" @default.
- Q79110018 name "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and PK of HPN217 in Patients With R/R MM" @default.
- Q79110018 name "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and PK of HPN217 in Patients With R/R MM" @default.
- Q79110018 type Item @default.
- Q79110018 label "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and PK of HPN217 in Patients With R/R MM" @default.
- Q79110018 label "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and PK of HPN217 in Patients With R/R MM" @default.
- Q79110018 prefLabel "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and PK of HPN217 in Patients With R/R MM" @default.
- Q79110018 prefLabel "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and PK of HPN217 in Patients With R/R MM" @default.
- Q79110018 P1050 Q79110018-4F329F96-818A-44DD-B02A-9044E3FBD51F @default.
- Q79110018 P1132 Q79110018-63A35C88-FD4A-4F72-89B6-AD98856056D8 @default.
- Q79110018 P1476 Q79110018-A32E566B-CCA2-4C36-84CE-5CEE9C5543DF @default.
- Q79110018 P2899 Q79110018-3E94D022-6942-4686-8402-DACF4212D07D @default.
- Q79110018 P3098 Q79110018-7EBB8E01-4C7F-4CB5-A976-2CBB031B60BA @default.
- Q79110018 P31 Q79110018-2332222E-141F-4D8E-8BB8-DCEB51A4A6C4 @default.
- Q79110018 P4135 Q79110018-7116F320-B595-47A5-9556-F05ED2397581 @default.
- Q79110018 P580 Q79110018-205E64F8-AB54-48FB-879F-0DB5DEBCA629 @default.
- Q79110018 P582 Q79110018-CE64869F-0FF0-4374-A0AC-50491F5EADDE @default.
- Q79110018 P6099 Q79110018-2D0F89A4-B78E-48F7-8B76-FD3B464EA778 @default.
- Q79110018 P6099 Q79110018-ACD25A21-738F-4668-8A72-533E30DFDFF4 @default.
- Q79110018 P8363 Q79110018-40B6A76F-967E-446D-8ABD-DC770204C06F @default.
- Q79110018 P1050 Q467635 @default.
- Q79110018 P1132 "+70" @default.
- Q79110018 P1476 "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients With Relapsed/Refractory Multiple Myeloma" @default.
- Q79110018 P2899 "+18" @default.
- Q79110018 P3098 "NCT04184050" @default.
- Q79110018 P31 Q30612 @default.
- Q79110018 P4135 "+100" @default.
- Q79110018 P580 "2020-01-02T00:00:00Z" @default.
- Q79110018 P582 "2024-01-02T00:00:00Z" @default.
- Q79110018 P6099 Q42824440 @default.
- Q79110018 P6099 Q5452194 @default.
- Q79110018 P8363 Q78089383 @default.